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ABSTRACT
Introduction The 2016 WHO antenatal guidelines 
propose evidence- based recommendations to improve 
maternal outcomes. We aim to complement these 
recommendations by describing and estimating the effects 
of the interventions recommended by WHO on maternal 
well- being or functioning.
Methods and analysis We will conduct a systematic 
review of experimental and quasi- experimental studies 
evaluating women’s well- being or functioning following the 
implementation of evidence- based antenatal interventions, 
published in peer- reviewed journals through a 15- year 
interval (2005–2020). The lead reviewer will screen all 
records identified at MEDLINE, EMBASE, CINAHL Plus, 
LILACS and SciELO. Two other reviewers will control 
screening strategy quality. Quality and risk of bias will 
be assessed using a specially designed instrument. Data 
synthesis will consider the instruments applied, how often 
they were used, conditions/interventions for positive or 
negative effects documented, statistical measures used to 
document effectiveness and how results were presented. A 
random- effects meta- analysis comparing frequently used 
instruments may be conducted.
Ethics and dissemination The study will be a systematic 
review with no human beings’ involvement, therefore not 
requiring ethical approval. Findings will be disseminated 
through peer- reviewed publication and scientific events.
PROSPERO registration number CRD42019143436.
INTRODUCTION
Antenatal care (ANC) is a key intervention 
to prevent women’s morbidity and mortality. 
Maternal morbidity has been recently defined 
by the WHO Maternal Morbidity Working 
Group (MMWG) as ‘any health condition 
attributed to and/or complicating pregnancy 
and childbirth that has a negative impact on 
the woman’s well- being and/or functioning’.1 
Well- being refers to women’s health- related 
quality of life (HRQoL), including their satis-
faction with their health status.2 Functioning 
relates to both physical and cognitive organic 
functions, as well as activities and participa-
tion in the family or in society, and it is the 
positive correlate of disability.3 4 Providing 
well- established healthcare for women during 
pregnancy is known to be an effective measure 
to enhance obstetric outcomes. Therefore, 
evidence- based recommendations that might 
reduce maternal morbidity and mortality 
have been brought together in many global 
and country- specific guidelines on ANC.5–7
In 2016, the WHO published its antenatal 
guidelines summarising and updating recom-
mendations available to improve maternal 
and perinatal health. The document added 
an innovative human rights- based approach 
for management of pregnancy- related compli-
cations, prioritising a person- centred model 
that results in a positive pregnancy experi-
ence with ANC. The 2016 WHO antenatal 
guidelines are a detailed manual that pres-
ents a narrative description of several recom-
mendations for specific health outcomes, and 
includes the level of evidence of the proposed 
interventions, classified as high, moderate 
and low certainty of evidence.8 Nonethe-
less, to date no guidelines have—so far as 
Strengths and limitations of this study
 ► Our systematic review will address an information 
gap on the extent to which key antenatal care in-
terventions may have positive or negative effects on 
women’s well- being and functioning.
 ► This will be the first systematic review on effects of 
antenatal interventions on maternal well- being and 
functioning.
 ► Our results could be directly integrated in future 
antenatal guidelines or recommendations, and they 
could also lead research teams working on future 
guidelines to include their own analysis of the ef-
fectiveness of interventions using functioning and 
well- being as outcomes.
 ► One study limitation will be the study being solely 
based on interventions recommended in the 2016 
WHO antenatal care guidelines, with only five inter-
ventions meeting our criteria of moderate/high cer-
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we are aware—addressed how recommended interven-
tions influence women’s well- being and/or functioning 
(both of which are key elements of the broader maternal 
morbidity concept).
Many validated instruments exist that either measure 
well- being or functioning through several predetermined 
dimensions, concerned for example with physical and 
psychological health status and functions, abilities to 
perform daily activities, social participation, self- esteem 
and satisfaction with heath.9 Frequently used instru-
ments of HRQoL include 36- Item Short Form Survey and 
WHO- Quality of Life, while WHO- Disability Assessment 
Schedule is a commonly used functioning instrument.10–12 
However, there is no consensus about which tool(s) 
most satisfactorily evaluate well- being and functioning 
during pregnancy and the postpartum period. Available 
instruments may include interviewer- administered, self- 
administered and proxy- administered questionnaires, 
using scores to identify women with important needs,13–16 
as well as qualitative evaluations.10–12 17–20 Several maternal 
health or disease- specific questionnaires also exist for 
assessing HRQoL during pregnancy.21–23
Maternal health has been under the scope of the Sustain-
able Development Goals (SDG) to be achieved until 
2030, especially through the highlighted ‘good health 
and well- being’ (SDG 3) and ‘gender equality’ (SDG 5)24 
goals. Thus, together with reduction of morbidity and 
mortality, future antenatal measures/actions/recommen-
dations should include promoting women’s well- being 
and functioning, comprising a positive pregnancy experi-
ence and preventing violence. It is crucial to gather infor-
mation available on which key healthcare interventions 
may have a positive effect on women’s well- being and/or 
functioning, so that they might be tested in intervention 
studies among different populations and settings in the 
future. From a long- term perspective, such information 
could be integrated in forthcoming ANC guidelines or 
recommendations.
Our objectives will be to compare, appraise and 
summarise studies focusing on evidence- based interven-
tions that are recommended in the WHO ANC guide-
lines and were applied during ANC, and that have/have 
not influenced maternal well- being or functioning. In 
the WHO ANC guidelines, evidence- based interventions 
consisted of treatment, procedures or more complex 
programmes that were evaluated using experimental 
and quasi- experimental studies as well as observational 
studies.
METHODS AND ANALYSIS
This will be a systematic review of experimental and quasi- 
experimental studies evaluating women’s well- being and 
functioning associated with or as a result of the implemen-
tation of selected evidence- based antenatal interventions. 
We aim to analyse whether well- established interventions 
applied to pregnant women have affected their well- being 
and functioning.
The period covered will be studies published from 2005 
until 2020. The initial search was already performed, and 
selection of studies is currently under quality analysis. 
There will be a language restriction to articles published 
in English, French, Portuguese and Spanish. The system-
atic review will follow the PRISMA- P statement (Preferred 
Reporting Items for Systematic Review and Meta- analysis 
Protocols)25 and has been registered at the International 
Prospective Register of Systematic Reviews.
For the present review, exposure will be interventions 
recommended for ANC because they reduce the occur-
rence of direct or indirect obstetric conditions, and 
outcome will be women’s well- being and/or functioning 
during pregnancy or after childbirth after receiving the 
recommended ANC interventions.
Eligibility criteria
There are no country/region inclusion or exclusion 
criteria. Included studies will have been conducted 
in primary care facilities, during home- based care or 
hospital- based care. The present review will include 
studies whose subjects are pregnant women at any gesta-
tional age, who have received one of the preselected inter-
ventions (outlined in the next paragraph), and who were 
evaluated from a well- being and functioning perspective 
(specifically designed tools/instruments or qualitative 
assessment) at any point in time during or after preg-
nancy. The inclusion of the postnatal period may provide 
data on longer term outcomes concerning well- being and 
functioning related to pregnancy.
The selection of interventions was based entirely on 
the 2016 WHO Antenatal Guideline.8 The WHO guide-
lines were intended to promote obstetric care within a 
broader framework, beyond prevention of death and 
morbidity, and to prioritise the applicability of interven-
tions in low- income and middle- income countries. We 
selected the WHO guidelines on account of their wide 
international circulation, as well as their use as a model 
for health policies around the world. Health promotion 
and identification of risk factors are within the scope of 
these guidelines, whereas treatment of complications 
and concurrent diseases are not. In order to account for 
women’s perspectives about the care provided to them, 
systematic reviews on women’s expectations on ANC were 
carried out, and the final version of the document was 
intended to promote well- being as part of the ‘positive 
pregnancy experience’.
The WHO guidelines list 49 recommendations 
grouped into 5 ‘types of interventions’ and concerning 
10 ‘maternal outcomes of interest’ (figure 1), as well 
as fetal and neonatal outcomes. Among the 49 recom-
mendations, 10 were included into the 2016 document 
from existing WHO guidelines approved by the review 
committee for the 2016 document. Evidence on the effec-
tiveness of interventions was obtained from 47 systematic 
reviews. Additionally, findings from a scoping review on 
women’s understanding of a positive ANC experience 
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settings suggested the importance of effective clinical 
practices, relevant and timely information, and psychoso-
cial and emotional support.26 Consideration of women’s 
perspectives was therefore applied together with quan-
titative evidence to evaluate the recommendations. The 
GRADE (Grading of Recommendations, Assessment, 
Development and Evaluations) approach was applied 
to appraise the quality of quantitative evidence.27 The 
quality of evidence was rated as ‘high’, ‘moderate’, ‘low’ 
or ‘very low’, with randomised controlled trials (RCTs) 
providing ‘high- quality’ evidence, while non- randomised 
trials and observational studies provided ‘low- quality or 
moderate- quality’ evidence. Qualitative reviews were 
appraised using the GRADE- CERQual tool.28
For the present systematic review, we reviewed the 49 
recommendations findings with respect to their effects 
on ‘maternal outcomes of interest’ only, in order to ascer-
tain the certainty of the evidence for the effectiveness of 
the intervention on women’s health improvement. We 
did not include maternal well- being and functioning 
outcomes for selecting interventions at this point. We 
found five interventions that were presented as having 
either a high or a moderate level of certainty of evidence 
associated with one or more of the listed ‘maternal 
outcomes of interest’. Those five interventions with high 
and moderate level of certainty of evidence will be further 
assessed in our systematic review to establish their effec-
tiveness in improving maternal well- being or functioning.
The five interventions described as improving maternal 
outcomes that will therefore be included in our system-
atic review are listed below:
1. Daily iron and folic acid supplementation: reduces 
puerperal infections and anaemia (when daily and in-
termittent supplementation were compared, favouring 
daily).
2. Multiple micronutrient supplementation: reduces 
anaemia (similar effect to iron and folic acid supple-
mentation).
3. Vitamin A supplementation: reduces anaemia (and 
night blindness at affected populations).
4. Diet and/or exercise: prevents hypertension and ex-
cessive weight gain (but not pre- eclampsia/eclampsia).
5. Midwife continuity of care: increases vaginal birth 
rates.
Data management
We will search MEDLINE, EMBASE, CINAHL Plus, 
LILACS and SciELO with customised search strategies 
for each electronic database according to their individual 
subject headings, syntax and searching structure. The 
search will combine free text and Medical Subject Head-
ings terms for the proposed interventions and maternal 
outcomes. For the maternal outcomes, we will apply 
keywords and index terms for the concepts of HRQoL, 
well- being and functioning. The search strategy is shown 
in online supplemental appendix 1.
Initially, CBA (lead reviewer) will select manuscripts 
by scrutinising their titles and abstracts, excluding those 
that are not related to the proposed objectives. To maxi-
mise the identification of all relevant results and ensure 
quality control, VF and JGC will look at a proportion of 
manuscripts to check whether they were included or not, 
until perfect matching in selection has been obtained. 
Following this step, we will assess the full text of the 
remaining documents, discarding irrelevant records, 
unless they can provide additional interpretation data. 
CBA will extract the data from relevant studies using a 
screening form specifically designed for the present 
review (online supplemental appendix 2) and examining 
their reference lists to identify additional papers for inclu-
sion. She will also scrutinise the reference lists of relevant 
literature reviews identified by our search strategy.
Prior to the final analysis, we will conduct a rerun of 
the searching strategy in order to check for more recent 
studies not initially included. Search results will be 
managed in EndNote and extracted data will be entered 
in an Excel spreadsheet.
We will list all instruments/questionnaires used for 
well- being and/or functioning measurement, and studies 
that applied the same instrument will be compared.
We will prepare a PRISMA flowchart to display results of 
the search, screening, review and extraction in a sequen-
tial manner, and a list of rejected articles along with the 
reasons for their exclusion.
Assessment of study quality/risk of bias
Two reviewers will appraise the data, and a third 
reviewer will be available for discussion if they are not 
in consensus. The planned analysis is a meta- analysis of 
published data in selected studies. The quality and risk 
of bias will be assessed using a tool specifically designed 
for this purpose, based on version 2 of Cochrane’s tool 
for assessing bias in randomised trials,29 and, if necessary, 
using statistical approach. For this, we included the bias 
domains and risk- of- bias questions in the study screening 
form (online supplemental appendix 2).
The dimensions analysed for bias include:
1. Sampling: What is the intended study population? 
(pregnant women with or without a condition; all 
pregnant women with a condition in the community; 
pregnant women attending health services; pregnant 
women with a condition attending health services; spe-
cial categories of women).
Figure 1 Maternal Outcomes of interest and types of 















pen: first published as 10.1136/bm





4 Andreucci CB, et al. BMJ Open 2021;11:e042667. doi:10.1136/bmjopen-2020-042667
Open access 
 – Detailed information written in full (extracted from 
manuscript) for the following:
 – Are the respondents representative of the intend-
ed study population?
 – Is there an adequate description of data collec-
tion location, including reasons for choice?
 – Is there an adequate description of inclusion and 
exclusion criteria? (sociodemographic character-
istics of the study population such as age, gesta-
tional length, ethnicity, level of education, parity, 
previous health condition and so on).
 – Ethical issues (is there a consent form?).
2. Completeness: Are there enough women interviewed 
and followed up?
 – Detailed information written in full (extracted from 
manuscript) and then simple yes/no answers for 
the following:
 – Is the sample size calculation adequate?
 – What was the follow- up rate? Are particular sub-
groups of women more likely to be lost to follow- 
up? Are reasons for loss of follow- up explained? 
(explanations in full text).
3. Study design: Is the study design described properly?
 – Detailed information written in full (extracted from 
manuscript) and then simple yes/no answers for 
the following:
 – Is the methodology adequate for drawing cited 
results/conclusions?
 – If the study is an RCT, was randomisation prop-
erly conducted?
 – If the study is an RCT, are investigators ascer-
taining outcomes blind to intervention alloca-
tion?
 – What certainty is there that health- related func-
tioning/well- being is a consequence of the 
evidence- based antenatal or postnatal interven-
tion?
4. Comparison: Is there a comparison group of preg-
nant/postpartum women without evidence- based in-
tervention?
 – Detailed information for each group written in full 
(extracted from manuscript) and then simple yes/
no answers for the following:
 – If the study has a quasi- experimental design, are 
there concurrent comparison groups and/or ‘be-
fore and after’ evaluations?
 – What was the content of care in the control 
group?
5. Validation: If a standardised tool was used, was the 
validity of the tool known or established for the pop-
ulation of interest (pregnant or postpartum women; 
women of reproductive age; preferably in the same 
geographical location)? (yes/no).
Do applied well- being/functioning instruments have 
appropriate psychometric properties? (yes/no).
6. Intervention: Did the authors describe the content 
and implementation of the selected intervention in 
sufficient detail? (yes/no).
7. Conceptualisation: Did the authors provide a defini-
tion of health- related functioning/well- being? (yes/
no).
Did the authors describe well- being and functioning 
instruments used? Are they correctly applied in the 
study? (yes/no).
Data synthesis
Among selected studies with any maternal outcome, our 
synthesis will consider the following:
 ► What were the instruments applied to evaluate well- 
being/functioning and how often were they used? 
What type of measures do they use?
 ► For which interventions have positive or negative 
effects been documented?
 ► What were the measures of effects used to quantify 
well- being or functioning?
 ► How were the results presented regarding impact on 
well- being/functioning?
 ► Can results from different studies be combined? 
(same instrument/methodology).
The findings of the systematic review will be displayed 
in tables with studies’ characteristics (sample, design, 
results). A table with listed studies and instruments will 
be provided, detailing methods, participants and results, 
as well as the appraisal of the quality of selected studies 
and questionnaires. We will apply GRADE to summarise 
the level of evidence available from our systematic review 
findings.27 Different HRQoL, well- being and functioning 
tools will be described according to their scoring systems, 
and then categorised in order to display their effects in 
an organised panel. We will calculate the proportion of 
studies with positive or negative effects for each selected 
intervention, and present the range of effects in a table 
format.
Finally, a narrative of the range of impact on well- 
being/functioning will be developed to summarise the 
findings. Fixed- effects or random- effects meta- analyses 
may be considered to analyse the results of the most 
frequently used well- being and functioning instruments, 
depending on the homogeneity of exposure/outcome 
characteristics.
Patient and public involvement
Patients or the public were not involved in the design, 
or conduct, or reporting, or dissemination plans of our 
study.
DISCUSSION
Recently, a standardised tool (WOICE) was developed 
by the WHO MMWG to identify maternal morbidity, 
recognising that there are many aspects of women’s lives 
which may be affected by ill- health during pregnancy 
or delivery.1 2 Applications of the WOICE tool revealed 
that the prevalence of self- reported ill- health was higher 
than appraised by health professionals,30 a conclusion 
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data with diagnoses.31 32 These findings suggest that preg-
nant women’s own perceptions of their health allow for a 
more comprehensive identification of the health- related 
burden of pregnancy and complications than diagnoses 
alone.
We plan to identify and describe good quality studies 
evaluating the influence of well- established antenatal 
interventions/recommendations on maternal well- being 
and functioning. Furthermore, we plan to meta- analyse 
findings from studies that applied the same measurement 
instrument and provide a summarised narrative of find-
ings from studies that could not be directly compared 
because of a lack of common instrument, but provided 
answers to our research question.
By the same token, our systematic review will provide 
much needed comprehensive insights on whether 
selected evidence- based interventions recommended for 
use during ANC have an impact on women’s self- reported 
well- being and/or functioning during pregnancy or 
postnatally, as well as on diagnoses of clinical condi-
tions. In addition, the review is likely to provide useful 
methodological insights on the instruments applied 
for this assessment, since it has been suggested that no 
currently available instrument is sufficiently comprehen-
sive to capture the particularities of functioning and well- 
being during the pregnancy, childbirth and postpartum 
period, and that there is a need for the development of 
a new maternity- specific tool.4 33 We believe our system-
atic review is likely to highlight interventions for which 
further evidence- based investigation is required, since 
documenting well- being and functioning during preg-
nancy and childbirth is relatively new, particularly in low- 
income and middle- income settings.
Pregnancy, childbirth and the postpartum period 
constitute a unique period during which women need to 
cope with physiological modifications while taking care 
of their child and frequently their household and profes-
sional career. The broader approach towards women’s 
health beyond reproductive aspects was already pointed 
as key measure to achieve sustainable development.34 The 
strain of being pregnant, giving birth and facing the post-
partum period may negatively impact women’s well- being 
and functioning, even more if during these circumstances 
women also struggle with morbidity or hypothetical 
unwanted outcomes from antenatal interventions.15 35 36 
Currently, we have no satisfactory means to properly iden-
tify and respond to these difficulties and empower women 
to thrive. Our proposed systematic review aligns with the 
objectives of the SDG in promoting well- being under a 
gender perspective.37
We searched through several antenatal guidelines 
including, for example, The National Institute for Health 
and Care Excellence, the American College of Obstetrics 
and Gynaecology, the International Federation of Gynae-
cology and Obstetrics, the Society of Obstetricians and 
Gynaecologists of Canada, the Pregnancy Care Guide-
lines from Australian Department of Health, guidelines 
from the Collège National des Gynécologues et Obstétriciens 
Français, guidelines for maternity care in South Africa and 
Brazilian guidelines for routine ANC. To the best of our 
knowledge, no available guidelines include an assessment 
of women’s well- being or functioning as part of their eval-
uation of the evidence base for their recommended inter-
ventions.5 6 38–43 Future clinical guidelines should not only 
recommend clinical evidence- based measures based on 
the treatment of diseases, but also take into account the 
possible positive or negative impact of interventions on 
women’s HRQoL or functioning.11 44 Appraising available 
evidence- based interventions recommended in the WHO 
ANC guidelines that have influenced maternal well- being 
or functioning might provide information to be inte-
grated in forthcoming ANC guidelines or recommenda-
tions, under a women’s well- being perspective.
ETHICS AND DISSEMINATION
The study will be a systematic review based on secondary 
data, therefore not requiring ethical approval. Patients 
were not directly involved in the study design, therefore 
dissemination of findings to participants is not applicable.
Any further amendments to this protocol will be docu-
mented and recorded in bibliographical databases.
The results will be disseminated using green or gold 
open access to ensure universal access for researchers, 
academics, caregivers and policymakers.
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